Jounce Therapeutics Inc.

NASDAQ: JNCE · Real-Time Price · USD
1.88
0.00 (0.00%)
At close: May 03, 2023, 10:00 PM

Jounce Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
150.57M 95.53M
Short-Term Investments
38.97M 83.04M
Long-Term Investments
n/a 41.66M
Other Long-Term Assets
3M 3.45M
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
7.69M 12.26M
Total Current Assets
197.23M 190.83M
Property-Plant & Equipment
12.32M 16.76M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
15.32M 61.87M
Total Assets
212.55M 252.7M
Account Payables
2.1M 1.67M
Deferred Revenue
n/a 13.47M
Short-Term Debt
4.15M 3.69M
Other Current Liabilities
17.32M 62K
Total Current Liabilities
23.57M 18.9M
Long-Term Debt
5.87M 9.99M
Other Long-Term Liabilities
n/a n/a
Total Long-Term Liabilities
5.87M 9.99M
Total Liabilities
29.44M 28.89M
Total Debt
10.02M 13.69M
Common Stock
51K 51K
Retained Earnings
-292.79M -241.87M
Comprehensive Income
-677K -238K
Shareholders Equity
183.11M 223.81M
Total Investments
38.97M 124.69M